Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 33069-62-4 | Product Number: P1632
Paclitaxel
Purity: >98.0%(HPLC)
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
100MG |
$325.00
|
1 | Contact Us | ≥100 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | P1632 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__4__7H__5__1NO__1__4 = 853.92 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 33069-62-4 |
Reaxys Registry Number | 4290260 |
PubChem Substance ID | 87558555 |
MDL Number | MFCD00869953 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Specific rotation | -49.0 to -54.0 deg(C=1, MeOH) |
Melting Point | 216 °C |
Specific Rotation | -52° (C=1,MeOH) |
Maximum Absorption Wavelength | 227(MeOH) nm |
Pictogram | |
Signal Word | Danger |
Hazard Statements | H302 + H312 + H332 : Harmful if swallowed, in contact with skin or if inhaled. H315 : Causes skin irritation. H319 : Causes serious eye irritation. H361 : Suspected of damaging fertility or the unborn child. H317 : May cause an allergic skin reaction. H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled. H341 : Suspected of causing genetic defects. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P285 : In case of inadequate ventilation wear respiratory protection. P201 : Obtain special instructions before use. P271 : Use only outdoors or in a well-ventilated area. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P272 : Contaminated work clothing must not be allowed out of the workplace. P342 + P311 : If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. P362 : Take off contaminated clothing and wash before reuse. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/doctor if you feel unwell. P304 + P340 + P312 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. P405 : Store locked up. |
RTECS# | DA8340750 |
HS Number | 2914.50.3000 |
Reference
- Taxol Induces Paraptosis Independent of Both Protein Synthesis and MAPK Pathway
- Taxol and taxotere: discovery, chemistry, and structure-activity relationships
- Microtubules as a target for anticancer drugs
- Paclitaxel-induced cell death: where the cell cycle and apoptosis come together
- Mechanism of action of antitumor drugs that interact with microtubules and tubulin
- A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
- R. C. Polomano, A. J. Mannes, U. S. Clark, G. J. Bennett, Pain 2001, 94, 293.
- Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy
- Cremophor EL the drawbacks and advantages of vehicle selection for drug formulation
- Paclitaxel and its formulations
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
References
References
References
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.